Dose-dense chemotherapy for breast cancer

The Breast Journal
Soley Bayraktar, Banu K Arun

Abstract

The concept of dose-dense chemotherapy has emerged and is based on the hypothesis that maximal chemotherapy effectiveness can be achieved by scheduling the interval of chemotherapy to correspond to the period of most rapid tumor growth, as predicted by preclinical models. The granulocyte-colony stimulating factor support has permitted the safe delivery of chemotherapy at shorter ("dose-dense") inter-treatment intervals. Several randomized trials have been conducted to test the feasibility and effectiveness of anthracycline and/or taxanes-based dose-dense strategies. They have been associated with a modest impact on disease recurrence and overall survival of patients with early-stage breast cancer. Subset analyses have suggested increased benefits for specific tumor subtypes such as hormone receptor-negative, highly proliferative or HER2 overexpressing tumors. This review article aims to outline the theoretical framework for dose-dense chemotherapy and summarizes the results of several recent clinical trials addressing this concept within neoadjuvant and adjuvant breast cancer treatment and discuss their implications for clinical practice. Further studies are needed to define the optimal regimen and the patient population that w...Continue Reading

References

Jun 1, 1977·Journal of the National Cancer Institute·L Norton, R Simon
Jan 1, 1989·Seminars in Surgical Oncology·R A SaezG M Clark
Feb 15, 1995·JAMA : the Journal of the American Medical Association·G BonadonnaP Valagussa
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I Craig HendersonLarry Norton
Apr 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martine J Piccart-Gebhart
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gianni BonadonnaPinuccia Valagussa
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marjorie C GreenGabriel N Hortobagyi
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Dec 8, 2005·Journal of the National Cancer Institute·Marco VenturiniPaolo Bruzzi
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Donald A BerryEric P Winer
Nov 29, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FountzilasUNKNOWN Hellenic Cooperative Oncology Group
Jan 5, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O GluzUNKNOWN West German Study Group
Apr 19, 2008·The New England Journal of Medicine·Joseph A SparanoNancy E Davidson
Jul 22, 2008·The New England Journal of Medicine·Sercan AksoyKadri Altundag

❮ Previous
Next ❯

Citations

Sep 23, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L SchwentnerUNKNOWN BRENDA study group
Apr 28, 2019·Breast Cancer Research and Treatment·Stephen P AcklandUNKNOWN for Breast Cancer Trials Ltd (formerly known as the Australia and New Zealand Breast Cancer Trials Group)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.